Skip all navigation and go to page content
NN/LM Home About PSR | Contact PSR | Feedback |Site Map | Help | Bookmark and Share

Clinical Advisory: NINDS Stops Treatment with Combination Antiplatelet Therapy Due to Higher Risk of Major Hemorrhage and Death

NINDS has stopped the combination antiplatelet intervention in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. This was a randomized, multicenter clinical trial conducted throughout North America, Latin America and Spain, to learn about preventing a second stroke in patients who had a subcortical stroke and to learn how to prevent cognitive problems after a stroke. Visit the NLM website for further information about the trial.

Comments are closed.